Skip to main content

What condition is Ingrezza used to treat?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Oct 23, 2024.

Official Answer by Drugs.com

Ingrezza (valbenazine) capsules and Ingrezza Sprinkle capsules are approved for the treatment of adults with tardive dyskinesia and for adults with chorea associated with Huntington's disease (HD), two types of involuntary movement disorders. Ingrezza is a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor.

Tardive dyskinesia (TD) is characterized by abnormal and repetitive movements of the trunk, extremities or face.

Huntington's disease (HD) is a hereditary disorder which causes cells in the brain to die. This leads to trouble with movement, thinking and emotions.

How do you take Ingrezza or Ingrezza Sprinkle?

Ingrezza and Ingrezza Sprinkle is a once daily oral medicine you take by mouth. Ingrezza and Ingrezza Sprinkle come as 40 mg, 60 mg and 80 mg capsules. It can be taken with or without food. Take Ingrezza exactly when your doctor tells you to take it.

If you take Ingrezza Sprinkle:

Your pharmacist or doctor can provide you with detailed written instructions on how to take Ingrezza Sprinkle. If you are not sure, ask your pharmacist.

Your doctor will tell you how much Ingrezza or Ingrezza Sprinkle to take and when to take it. Your dose will be slowly increased to help lessen side effects and evaluate your response. Do not stop taking this medicine without first speaking to your doctor.

You may need a lower dose if you have liver disease or take certain medications.

It is not known if Ingrezza is safe and effective for use in children.

Related: Ingrezza dosing (in more detail)

Related questions

Is Ingrezza an antipsychotic agent?

No, Ingrezza is not an antipsychotic agent. It is a VMAT2 inhibitor (vesicular monoamine transporter-2 inhibitor).

It works by blocking VMAT2 to slow the uptake of a brain chemical known as dopamine. This helps to reduce the unwanted body movements of tardive dyskinesia (TD) caused by long-term use of antipsychotics and of chorea associated with Huntington’s disease.

Antipsychotics medicines are often use to treat bipolar disorder, depression or schizophrenia.

This is not all the information you need to know about Ingrezza (valbenazine) for safe and effective use. Review the full Ingrezza information and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

Does Ingrezza cause weight gain?

Weight gain has been reported in a 6-week clinical study with Ingrezza, but it is not a common side effect. Of 151 patients taking either the 40 mg/day or 80 mg/day dose, 3 patients had weight gain (2%) compared to zero patients (0%) in the placebo (inactive treatment) group. Continue reading

Ingrezza mechanism of action: How does it work?

Experts aren’t sure exactly how Ingrezza works but suggest it blocks a protein transporter called vesicular monoamine transporter 2 (VMAT2), which is responsible for regulating the uptake of neurotransmitters such as dopamine. The abnormal functioning of dopamine is thought to be a cause of tardive dyskinesia (TD) and chorea associated with Huntington's disease (HD). By blocking VMAT2, Ingrezza reduces the uptake of dopamine, causing a decrease in symptoms of TD and chorea.

Continue reading

Can Ingrezza capsules be opened?

Ingrezza Sprinkle capsules can be opened and sprinkled on soft food, such as applesauce, yogurt or pudding before swallowing. Do not chew the granules before swallowing. If you use the regular Ingrezza capsule that is swallowed and not sprinkled, do not open, cut, crush or split the capsule without your doctor’s advice. Continue reading

See also:

Related medical questions

Drug information

Related support groups